Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease
DR Cook, KL Rossman, CJ Der - Oncogene, 2014 - nature.com
The aberrant activity of Ras homologous (Rho) family small GTPases (20 human members)
has been implicated in cancer and other human diseases. However, in contrast to the direct …
has been implicated in cancer and other human diseases. However, in contrast to the direct …
Androgen receptor signaling in prostate cancer
The androgen receptor (AR), ligand-induced transcription factor, is expressed in primary
prostate cancer and in metastases. AR regulates multiple cellular events, proliferation …
prostate cancer and in metastases. AR regulates multiple cellular events, proliferation …
Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex
HV Heemers, DJ Tindall - Endocrine reviews, 2007 - academic.oup.com
Androgens, acting through the androgen receptor (AR), are responsible for the development
of the male phenotype during embryogenesis, the achievement of sexual maturation at …
of the male phenotype during embryogenesis, the achievement of sexual maturation at …
Targeting Rac and Cdc42 GEFs in metastatic cancer
MDM Maldonado, JI Medina, L Velazquez… - Frontiers in cell and …, 2020 - frontiersin.org
The Rho family GTPases Rho, Rac, and Cdc42 have emerged as key players in cancer
metastasis, due to their essential roles in regulating cell division and actin cytoskeletal …
metastasis, due to their essential roles in regulating cell division and actin cytoskeletal …
Approaches of targeting Rho GTPases in cancer drug discovery
Y Lin, Y Zheng - Expert opinion on drug discovery, 2015 - Taylor & Francis
Introduction: Rho GTPases are master regulators of actomyosin structure and dynamics and
play pivotal roles in a variety of cellular processes including cell morphology, gene …
play pivotal roles in a variety of cellular processes including cell morphology, gene …
[HTML][HTML] Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1
B Yu, IRS Martins, P Li, GK Amarasinghe, J Umetani… - Cell, 2010 - cell.com
Vav proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases. They
control processes including T cell activation, phagocytosis, and migration of normal and …
control processes including T cell activation, phagocytosis, and migration of normal and …
Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models
RB Marques, NF Dits, S Erkens-Schulze… - PloS one, 2010 - journals.plos.org
Background Prostate cancer is initially dependent on androgens for survival and growth,
making hormonal therapy the cornerstone treatment for late-stage tumors. However, despite …
making hormonal therapy the cornerstone treatment for late-stage tumors. However, despite …
The Vav GEF family: An evolutionary and functional perspective
S Rodríguez-Fdez, XR Bustelo - Cells, 2019 - mdpi.com
Vav proteins play roles as guanosine nucleotide exchange factors for Rho GTPases and
signaling adaptors downstream of protein tyrosine kinases. The recent sequencing of the …
signaling adaptors downstream of protein tyrosine kinases. The recent sequencing of the …
Guanine nucleotide exchange factors for RhoGTPases: good therapeutic targets for cancer therapy?
G Lazer, S Katzav - Cellular signalling, 2011 - Elsevier
Rho guanosine triphosphatases (GTPases) are a family of small proteins which function as
molecular switches in a variety of signaling pathways following stimulation of cell surface …
molecular switches in a variety of signaling pathways following stimulation of cell surface …
Androgen receptor coactivators in regulation of growth and differentiation in prostate cancer
Z Culig - Journal of cellular physiology, 2016 - Wiley Online Library
Androgen receptor (AR) is a key factor in regulation of growth and differentiation in normal
and malignant prostate. Endocrine therapies for prostate cancer include inhibition of …
and malignant prostate. Endocrine therapies for prostate cancer include inhibition of …